Concepedia

Brian E. Toki

BE

Statistics

Publications

14

Citations

3.8K

H-Index

14

Active since

1998

Affiliations

Seagen (United States)(Current)

Arizona State University

Cancer Research Institute

Brian E. Toki is an author at Seagen (United States) specializing in pharmacy, medicinal chemistry, and antibody-drug conjugates.

Publications per year

1998–2016

14

Publications

14

Development of potent monoclonal antibody auristatin conjugates for cancer therapy

Svetlana O. Doronina, Brian E. Toki, Michael Torgov et al. · Nature Biotechnology · 2003 · 1.2K citations

, , +14

cAC10-vcMMAE, an anti-CD30–monomethyl auristatin E conjugate with potent and selective antitumor activity

Joseph A. Francisco, Charles G. Cerveny, Damon L. Meyer et al. · Blood · 2003 · 921 citations

, , +11

Enhanced Activity of Monomethylauristatin F through Monoclonal Antibody Delivery:  Effects of Linker Technology on Efficacy and Toxicity

Svetlana O. Doronina, Brian A. Mendelsohn, Tim D. Bovee et al. · Bioconjugate Chemistry · 2005 · 512 citations

, , +17

Antineoplastic Agents. 379. Synthesis of Phenstatin Phosphate<sup>1a,</sup>

George R. Pettit, Brian E. Toki, Delbert L. Herald et al. · Journal of Medicinal Chemistry · 1998 · 237 citations · Full text

, , +15

Development of orally active inhibitors of protein and cellular fucosylation

Nicole M. Okeley, Stephen C. Alley, Martha E. Anderson et al. · Proceedings of the National Academy of Sciences · 2013 · 192 citations · Full text

, , +17

1–5 of 14